Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 3
2020 5
2021 3
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean yuqing cao (88 results)?
Targeting Bcl-2 Proteins in Acute Myeloid Leukemia.
Wei Y, Cao Y, Sun R, Cheng L, Xiong X, Jin X, He X, Lu W, Zhao M. Wei Y, et al. Among authors: cao y. Front Oncol. 2020 Nov 5;10:584974. doi: 10.3389/fonc.2020.584974. eCollection 2020. Front Oncol. 2020. PMID: 33251145 Free PMC article. Review.
Corrigendum: Targeting Bcl-2 Proteins in Acute Myeloid Leukemia.
Wei Y, Cao Y, Sun R, Cheng L, Xiong X, Jin X, He X, Lu W, Zhao M. Wei Y, et al. Among authors: cao y. Front Oncol. 2020 Dec 17;10:632775. doi: 10.3389/fonc.2020.632775. eCollection 2020. Front Oncol. 2020. PMID: 33392100 Free PMC article.
CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual disease.
Lu W, Wei Y, Cao Y, Xiao X, Li Q, Lyu H, Jiang Y, Zhang H, Li X, Jiang Y, Meng J, Yuan T, Zhu H, He X, Jin X, Sun R, Sui T, Liu K, Zhao M. Lu W, et al. Among authors: cao y. Cancer Immunol Immunother. 2021 Dec;70(12):3501-3511. doi: 10.1007/s00262-021-02941-4. Epub 2021 Apr 25. Cancer Immunol Immunother. 2021. PMID: 33899130 Free PMC article. Clinical Trial.
HLA-matched and HLA-haploidentical allogeneic CD19-directed chimeric antigen receptor T-cell infusions are feasible in relapsed or refractory B-cell acute lymphoblastic leukemia before hematopoietic stem cell transplantation.
Jin X, Cao Y, Wang L, Sun R, Cheng L, He X, Xiao X, Jiang Y, Li Q, Zhang H, Lu W, Lyu C, Jiang Y, Meng J, Zhao M. Jin X, et al. Among authors: cao y. Leukemia. 2020 Mar;34(3):909-913. doi: 10.1038/s41375-019-0610-x. Epub 2019 Oct 18. Leukemia. 2020. PMID: 31628429 Free PMC article. No abstract available.
13 results